Closing gaps in medication taking for secondary prevention of coronary heart disease patients among US adults
Background: The secondary preventive medical remedies used in the U.S. general population, particularly those with numerous co-morbidities, are poorly understood. We aimed to assess health outcomes and the extent of their adherence to guideline-based secondary prevention medications among U.S. coron...
Main Authors: | Xiaowei Liu, Lijiang Tang, Ying Tang, Changqing Du, Xiaofeng Chen, Cheng Xu, Jing Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844022028183 |
Similar Items
-
The secondary prevention of coronary heart disease in US adults 75 Years and older in daily practice: Results from the National Health and Nutrition Examination Survey 1999–2018 survey
by: Zhi Zhang, et al.
Published: (2024-04-01) -
Secondary Prevention of Coronary Heart Disease in Primary Health Care
by: Olivera Batić-Mujanović, et al.
Published: (2006-05-01) -
Revisiting secondary prevention in coronary heart disease
by: Alben Sigamani, et al.
Published: (2022-11-01) -
Comparison of secondary prevention in coronary heart disease patients living in rural and urban areas
by: Salih Kılıç, et al.
Published: (2019-03-01) -
Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial
by: Anete Kaldal, et al.
Published: (2023-04-01)